Partnership to Create a Genetic Analysis Service and European Demonstration Facility

IntegraGen will offer premium class services to its customers using the Fluidigm BioMark system for genetic analysis and the access array sample-preparation system for next-generation sequencing. IntegraGen's lab will also be a demonstration site for European researchers investigating Fluidigm's technology.

Fluidigm instrumentation, combined with its microfluidic-based chips, provide high-performance, high throughput gene expression, genotyping, digital polymerase chain reaction (PCR), and sample preparation for next-generation sequencing.

"With this wonderful partnership, researchers will be able to immediately utilize IntegraGen's premiere services based on Fluidigm technology and enjoy the benefits of integrated fluidic circuits. In addition, Fluidigm will have a demonstration site for our European customers to observe and understand the easy workflow and other unique capabilities of our technology,” said Dominique Remy-Renou, Fluidigm's vice president of European sales and support.

"IntegraGen is proud to be able to provide Fluidigm's technology to its customers. These tools complete the IntegraGen Services portfolio and put our lab at the cutting edge of genotyping and next generation sequencing capabilities,” said Emmanuel Martin, director of genomic services at IntegraGen.

Fluidigm develops, manufactures, and markets proprietary IFC systems that improve productivity in life-science research. Fluidigm's IFCs enable the simultaneous performance of thousands of sophisticated biochemical measurements in extremely minute volumes. These "integrated circuits for biology” are made possible by miniaturizing and integrating liquid handling components on a single microfluidic device (IFC). Fluidigm products are only available for research use.

IntegraGen is focused on gene discovery and the commercialization of molecular diagnostics products and services that provide clinicians with new tools to personalize diagnosis, treatment, and therapy. With discovery and intellectual property focused on diabetes, obesity, bipolar disorders, schizophrenia, and autism, IntegraGen's core strategy is to deliver a range of high-value molecular diagnostic products and services that drive personalized healthcare solutions for complex diseases. The Genetic Services Business provides genotyping services to the research community.

Related Links:
Fluidigm
IntegraGen